Literature DB >> 32863603

The antimicrobial activity of bovine milk xanthine oxidase.

Gulustan Ozturk1, Ishita M Shah1,2, David A Mills1,2, J Bruce German1,2, Juliana M L N de Moura Bell1,3.   

Abstract

Mammalian milk is a source of antimicrobial compounds such as xanthine oxidase (XO). The interplay of infant saliva, which contains the substrates for XO activity, and human milk containing XO has been recently shown to inhibit the growth of pathogenic bacteria. Based on the complex and protective mechanism observed in human milk, we hypothesized that bovine milk XO operates similarly, thus representing an opportunity to investigate its functionality in broader health implications. We demonstrated that bovine milk-hypoxanthine mixture (0 to 400 μM) inhibited several Gram-negative and -positive bacterial pathogens in a dose-dependent manner. Kinetic experiments revealed that XO catalyzed hypoxanthine reduction (Km, 58.0 μM; Vmax, 5.1 μmol-1 min-1 mg) resulted in the production of antimicrobial hydrogen peroxide. These results demonstrate that the antimicrobial properties of bovine milk XO are similar to those of human milk XO with significant implications for the development of novel products targeting infant health.

Entities:  

Year:  2019        PMID: 32863603      PMCID: PMC7451117          DOI: 10.1016/j.idairyj.2019.104581

Source DB:  PubMed          Journal:  Int Dairy J        ISSN: 0958-6946            Impact factor:   3.032


  24 in total

1.  Antibacterial properties of xanthine oxidase in human milk.

Authors:  C R Stevens; T M Millar; J G Clinch; J M Kanczler; T Bodamyali; D R Blake
Journal:  Lancet       Date:  2000-09-02       Impact factor: 79.321

Review 2.  Xanthine oxidase is a peroxynitrite synthase: newly identified roles for a very old enzyme.

Authors:  Timothy M Millar; Janos M Kanczler; Tulin Bodamyali; David R Blake; Cliff R Stevens
Journal:  Redox Rep       Date:  2002       Impact factor: 4.412

Review 3.  Xanthine oxidoreductase is central to the evolution and function of the innate immune system.

Authors:  Claudia Vorbach; Roger Harrison; Mario R Capecchi
Journal:  Trends Immunol       Date:  2003-09       Impact factor: 16.687

4.  Antimicrobial properties of milk: dependence on presence of xanthine oxidase and nitrite.

Authors:  John T Hancock; Vyv Salisbury; Maria Cristina Ovejero-Boglione; Robert Cherry; Catherine Hoare; Robert Eisenthal; Roger Harrison
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

5.  Physicochemical and kinetic properties of purified sheep's milk xanthine oxidoreductase.

Authors:  Mustapha Benboubetra; Abderahmene Baghiani; Djebbar Atmani; Roger Harrison
Journal:  J Dairy Sci       Date:  2004-06       Impact factor: 4.034

6.  THE ANTIBACTERIAL EFFECT OF ENZYMATIC XANTHINE OXIDATION.

Authors:  F Lipmann; C R Owen
Journal:  Science       Date:  1943-09-10       Impact factor: 47.728

Review 7.  Breast milk oligosaccharides: structure-function relationships in the neonate.

Authors:  Jennifer T Smilowitz; Carlito B Lebrilla; David A Mills; J Bruce German; Samara L Freeman
Journal:  Annu Rev Nutr       Date:  2014-05-15       Impact factor: 11.848

Review 8.  Milk xanthine oxidoreductase: the first one hundred years.

Authors:  V Massey; C M Harris
Journal:  Biochem Soc Trans       Date:  1997-08       Impact factor: 5.407

9.  Influence of storage, heat, and homogenization upon xanthine oxidase activity of milk.

Authors:  B J Demott; O A Praepanitchai
Journal:  J Dairy Sci       Date:  1978-02       Impact factor: 4.034

10.  The effect of breastmilk and saliva combinations on the in vitro growth of oral pathogenic and commensal microorganisms.

Authors:  E L Sweeney; S S Al-Shehri; D M Cowley; H G Liley; N Bansal; B G Charles; P N Shaw; J A Duley; C L Knox
Journal:  Sci Rep       Date:  2018-10-11       Impact factor: 4.379

View more
  1 in total

1.  Sequence characterisation and novel insights into bovine mastitis-associated Streptococcus uberis in dairy herds.

Authors:  Ben Vezina; John I Alawneh; Hulayyil Al-Harbi; Hena R Ramay; Martin Soust; Robert J Moore; Timothy W J Olchowy
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.